Article
GSK3β inactivation promotes the oncogenic functions of EZH2 and enhances methylation of H3K27 in human breast cancers.
Oncotarget - 30 Aug 2016
Ko How-Wen, Lee Heng-Huan, Huo Longfei, Xia Weiya, Yang Cheng-Chieh, Hsu Jennifer L, Li Long-Yuan, Lai Chien-Chen, Chan Li-Chuan, Cheng Chien-Chia, Labaff Adam M, Liao Hsin-Wei, Lim Seung-Oe, Li Chia-Wei, Wei Yongkun, Nie Lei, Yamaguchi Hirohito, Hung Mien-Chie
Abstract excerpt
During the process of tumorigenesis, inactivation of tumor suppressors is a critical step. EZH2, a histone methyltransferase, promotes cell growth and migration through catalyzing trimethylation of histone H3 at Lys 27 (H3K27me3) and plays an important role in tumorigenesis. Its expression can be controlled by phosphorylation. However, the regulation of EZH2 activity by tumor suppressor kinase is not well...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
